Clinical Trials Browser

Phase 2 × Melanoma × cositecan × Clear all

NCT00062491 2020-03-12

Study of Karenitecin (BNP1350) to Treat Malignant Melanoma

Phase 2 Completed

Melanoma, Neoplasms